ATE500825T1 - Verwendung von tiotropium-salzen bei der behandlung von mässigem persistierendem asthma - Google Patents

Verwendung von tiotropium-salzen bei der behandlung von mässigem persistierendem asthma

Info

Publication number
ATE500825T1
ATE500825T1 AT06830792T AT06830792T ATE500825T1 AT E500825 T1 ATE500825 T1 AT E500825T1 AT 06830792 T AT06830792 T AT 06830792T AT 06830792 T AT06830792 T AT 06830792T AT E500825 T1 ATE500825 T1 AT E500825T1
Authority
AT
Austria
Prior art keywords
treatment
tiotropium salts
persistent asthma
moderate persistent
moderate
Prior art date
Application number
AT06830792T
Other languages
English (en)
Inventor
Michael Engel
Stefan Heinrichs
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35695896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE500825(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE500825T1 publication Critical patent/ATE500825T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT06830792T 2006-01-04 2006-12-22 Verwendung von tiotropium-salzen bei der behandlung von mässigem persistierendem asthma ATE500825T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100055 2006-01-04
PCT/EP2006/070135 WO2007077162A1 (en) 2006-01-04 2006-12-22 Use of tiotropium salts in the treatment of moderate persistent asthma

Publications (1)

Publication Number Publication Date
ATE500825T1 true ATE500825T1 (de) 2011-03-15

Family

ID=35695896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06830792T ATE500825T1 (de) 2006-01-04 2006-12-22 Verwendung von tiotropium-salzen bei der behandlung von mässigem persistierendem asthma

Country Status (30)

Country Link
US (2) US20070155773A1 (de)
EP (1) EP1971332B1 (de)
JP (1) JP2009525950A (de)
KR (1) KR20080083060A (de)
CN (1) CN101355937A (de)
AR (1) AR059126A1 (de)
AT (1) ATE500825T1 (de)
AU (1) AU2006334367B2 (de)
BR (1) BRPI0620886A2 (de)
CA (1) CA2634984C (de)
CY (1) CY1111534T1 (de)
DE (1) DE602006020620D1 (de)
DK (1) DK1971332T3 (de)
EA (1) EA015353B1 (de)
EC (1) ECSP088588A (de)
ES (1) ES2362306T3 (de)
HR (1) HRP20110200T1 (de)
IL (1) IL192602A (de)
ME (1) ME01205B (de)
MY (1) MY146362A (de)
NO (1) NO20082439L (de)
NZ (1) NZ570162A (de)
PL (1) PL1971332T3 (de)
PT (1) PT1971332E (de)
RS (1) RS51703B (de)
SI (1) SI1971332T1 (de)
TW (1) TW200731976A (de)
UA (1) UA95271C2 (de)
WO (1) WO2007077162A1 (de)
ZA (1) ZA200804436B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101237872A (zh) 2005-08-06 2008-08-06 贝林格尔·英格海姆国际有限公司 噻托铵盐在治疗严重持续性哮喘中的用途
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN110876721A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 一种含有表面活性剂的噻托溴铵喷雾剂
CN110876720A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2425539A (en) * 1942-10-31 1947-08-12 Aro Equipment Corp Coupling
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
DK1326862T3 (da) * 2000-10-12 2004-11-22 Boehringer Ingelheim Pharma Krystallinsk monohydrat af tiotropiumbromid, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddel
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
PT1682542E (pt) * 2003-11-03 2010-01-27 Boehringer Ingelheim Int Novo anidrato cristalino com actividade anticolinérgica
EA012326B1 (ru) * 2003-11-03 2009-08-28 Бёрингер Ингельхайм Интернациональ Гмбх Способ получения солей тиотропия, соли тиотропия, а также содержащие их лекарственные композиции
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
EP1896607A4 (de) * 2005-05-10 2009-12-16 Synergenz Bioscience Ltd Verfahren und zusammensetzungen zur beurteilung der lungenfunktion und von lungenerkrankungen
EP1888779A4 (de) * 2005-05-20 2009-06-10 Synergenz Bioscience Ltd Verfahren zur analyse von polymorphismen sowie verwendungen davon
CN101237872A (zh) * 2005-08-06 2008-08-06 贝林格尔·英格海姆国际有限公司 噻托铵盐在治疗严重持续性哮喘中的用途
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide

Also Published As

Publication number Publication date
IL192602A (en) 2013-06-27
ES2362306T3 (es) 2011-07-01
CN101355937A (zh) 2009-01-28
ECSP088588A (es) 2008-07-30
KR20080083060A (ko) 2008-09-12
AU2006334367B2 (en) 2012-11-08
JP2009525950A (ja) 2009-07-16
IL192602A0 (en) 2009-09-22
ZA200804436B (en) 2008-12-31
CA2634984A1 (en) 2007-07-12
NZ570162A (en) 2011-09-30
BRPI0620886A2 (pt) 2011-11-29
UA95271C2 (ru) 2011-07-25
RS51703B (sr) 2011-10-31
PT1971332E (pt) 2011-03-18
SI1971332T1 (sl) 2011-05-31
EA200801629A1 (ru) 2008-12-30
CY1111534T1 (el) 2015-08-05
TW200731976A (en) 2007-09-01
PL1971332T3 (pl) 2011-08-31
NO20082439L (no) 2008-08-04
AU2006334367A1 (en) 2007-07-12
HRP20110200T1 (hr) 2011-04-30
EA015353B1 (ru) 2011-06-30
CA2634984C (en) 2014-05-06
WO2007077162A1 (en) 2007-07-12
US20070155773A1 (en) 2007-07-05
EP1971332A1 (de) 2008-09-24
AR059126A1 (es) 2008-03-12
DK1971332T3 (da) 2011-04-18
US20150224090A1 (en) 2015-08-13
EP1971332B1 (de) 2011-03-09
ME01205B (me) 2013-03-20
DE602006020620D1 (de) 2011-04-21
MY146362A (en) 2012-08-15

Similar Documents

Publication Publication Date Title
CY2020043I1 (el) Παγιδες gdf για χρηση στη θεραπευτικη αντιμετωπιση της αναιμιας
EP2060040A4 (de) Verwendung von satztokens in transaktionen
CO6751293A2 (es) Derivados heterocíclicos novedosos y su uso en e tratamiento de trastornos neurológicos
SI2084151T1 (sl) Substituirani dihidropirazoloni za zdravljenje kardiovaskularnih in hematoloških bolezni
EE05394B1 (et) Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
DK2049614T3 (da) Keramisk proppant med lav vægtfylde
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
BRPI0908906A2 (pt) compostos heterocíclicos e usos dos mesmos
ATE550329T1 (de) Heterobicyclische sulfonamidderivate zur behandlung von diabetes
DK2426106T3 (da) Piperidin- og piperazinderivat til behandling af tumorer
BR112013013790A2 (pt) compostos heterocíclos nitrogenosos 6,6-fundidos substituídos e usos dos mesmos
EP2288324A4 (de) Saugfähiger hygieneartikel mit einweglasche
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
DOP2006000066A (es) Nueva sal y polimorfos del inhibidor de la dpp-iv
DE602006004463D1 (de) Kristallform von asenapinmaleat
ATE521365T1 (de) Kinin-antagonisten zur behandlung von blasenfunktionsstörung
EP1835919A4 (de) Behandlung trockener augen
DK2323644T3 (da) N-substituerede benzenpropanamid- eller benzenpropenamidderivater til anvendelse ved behandlingen af smerte
BRPI0818121A2 (pt) diespiro 1,2,4-trioxolano e seus métodos de fabricação e utilização
DK2004214T3 (da) Lokalbehandling med faktor VII
BRPI0923878A2 (pt) Inibidores de giyt1 bicíclicos 3.1.0 e métodos de produção e uso dos mesmos.
HRP20150320T1 (xx) Formulacije i metode za lijeäśenje amiloidoze
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
IL192602A0 (en) Use of tiotropium salts in the treatment of moderate persistent asthma
IL189248A0 (en) Use of tiotropium salts in the treatment of severe persistant asthma

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1971332

Country of ref document: EP